Flavia De Angelis

Flavia De Angelis

Université de Sherbrooke - Sherbrooke / Canada
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 664864
University of Sherbrooke
person_outline Flavia De Angelis's MOST POPULAR ARTICLES
1-) Pembrolizumab plus chemotherapy in metastatic non–small-cell lung cancerL Gandhi, D Rodríguez-Abreu, S Gadgeel, E Esteban, E Felip, ...New England journal of medicine 378 (22), 2078-2092, 201841922018
2-) Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label …TSK Mok, YL Wu, I Kudaba, DM Kowalski, BC Cho, HZ Turna, G Castro Jr, ...The Lancet 393 (10183), 1819-1830, 201919832019
3-) Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189D Rodríguez-Abreu, SF Powell, MJ Hochmair, S Gadgeel, E Esteban, ...Annals of Oncology 32 (7), 881-895, 20211972021
4-) Aging, immunity, and cancerT Fulop, A Larbi, R Kotb, F de Angelis, G PawelecDiscovery medicine 11 (61), 537-550, 20111912011
5-) Potential role of immunosenescence in cancer developmentT Fulop, R Kotb, CF Fortin, G Pawelec, F De Angelis, A LarbiAnnals of the new York Academy of Sciences 1197 (1), 158-165, 20101902010